These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 21998091)

  • 1. P450(BM3) on steroids: the Swiss Army knife P450 enzyme just gets better.
    Wong LL
    Chembiochem; 2011 Nov; 12(17):2537-9. PubMed ID: 21998091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active site substitution A82W improves the regioselectivity of steroid hydroxylation by cytochrome P450 BM3 mutants as rationalized by spin relaxation nuclear magnetic resonance studies.
    Rea V; Kolkman AJ; Vottero E; Stronks EJ; Ampt KA; Honing M; Vermeulen NP; Wijmenga SS; Commandeur JN
    Biochemistry; 2012 Jan; 51(3):750-60. PubMed ID: 22208729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regio- and stereoselectivity of P450-catalysed hydroxylation of steroids controlled by laboratory evolution.
    Kille S; Zilly FE; Acevedo JP; Reetz MT
    Nat Chem; 2011 Aug; 3(9):738-43. PubMed ID: 21860465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
    Roitel O; Scrutton NS; Munro AW
    Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A highly active single-mutation variant of P450BM3 (CYP102A1).
    Whitehouse CJ; Bell SG; Yang W; Yorke JA; Blanford CF; Strong AJ; Morse EJ; Bartlam M; Rao Z; Wong LL
    Chembiochem; 2009 Jul; 10(10):1654-6. PubMed ID: 19492389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of the stereo-selectivity of styrene epoxidation by cytochrome P450 BM3 using structure-based mutagenesis.
    Huang WC; Cullis PM; Raven EL; Roberts GC
    Metallomics; 2011 Apr; 3(4):410-6. PubMed ID: 21240430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel semi-biosynthetic route for artemisinin production using engineered substrate-promiscuous P450(BM3).
    Dietrich JA; Yoshikuni Y; Fisher KJ; Woolard FX; Ockey D; McPhee DJ; Renninger NS; Chang MC; Baker D; Keasling JD
    ACS Chem Biol; 2009 Apr; 4(4):261-7. PubMed ID: 19271725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering bacterial cytochrome P450 (P450) BM3 into a prototype with human P450 enzyme activity using indigo formation.
    Park SH; Kim DH; Kim D; Kim DH; Jung HC; Pan JG; Ahn T; Kim D; Yun CH
    Drug Metab Dispos; 2010 May; 38(5):732-9. PubMed ID: 20100815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biocatalytic route to chiral acyloins: P450-catalyzed regio- and enantioselective α-hydroxylation of ketones.
    Agudo R; Roiban GD; Lonsdale R; Ilie A; Reetz MT
    J Org Chem; 2015 Jan; 80(2):950-6. PubMed ID: 25495724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of engineered cytochrome P450 mutants as biocatalysts for the synthesis of benzylic and aromatic metabolites of fenamic acid NSAIDs.
    Venkataraman H; Verkade-Vreeker MC; Capoferri L; Geerke DP; Vermeulen NP; Commandeur JN
    Bioorg Med Chem; 2014 Oct; 22(20):5613-20. PubMed ID: 24999003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure, electronic properties and catalytic behaviour of an activity-enhancing CYP102A1 (P450(BM3)) variant.
    Whitehouse CJ; Yang W; Yorke JA; Tufton HG; Ogilvie LC; Bell SG; Zhou W; Bartlam M; Rao Z; Wong LL
    Dalton Trans; 2011 Oct; 40(40):10383-96. PubMed ID: 21603690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome P450 catalyzed oxidative hydroxylation of achiral organic compounds with simultaneous creation of two chirality centers in a single C-H activation step.
    Roiban GD; Agudo R; Reetz MT
    Angew Chem Int Ed Engl; 2014 Aug; 53(33):8659-63. PubMed ID: 24590553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P450(BM3) (CYP102A1): connecting the dots.
    Whitehouse CJ; Bell SG; Wong LL
    Chem Soc Rev; 2012 Feb; 41(3):1218-60. PubMed ID: 22008827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of a minimal enriched P450 BM3 mutant library for hydroxylation of cyclic and acyclic alkanes.
    Weber E; Seifert A; Antonovici M; Geinitz C; Pleiss J; Urlacher VB
    Chem Commun (Camb); 2011 Jan; 47(3):944-6. PubMed ID: 21079837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of protein plasticity in computational rationalization studies on regioselectivity in testosterone hydroxylation by cytochrome P450 BM3 mutants.
    de Beer SB; van Bergen LA; Keijzer K; Rea V; Venkataraman H; Guerra CF; Bickelhaupt FM; Vermeulen NP; Commandeur JN; Geerke DP
    Curr Drug Metab; 2012 Feb; 13(2):155-66. PubMed ID: 22208530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA-mediated assembly of cytochrome P450 BM3 subdomains.
    Erkelenz M; Kuo CH; Niemeyer CM
    J Am Chem Soc; 2011 Oct; 133(40):16111-8. PubMed ID: 21919448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single active site mutation inverts stereoselectivity of 16-hydroxylation of testosterone catalyzed by engineered cytochrome P450 BM3.
    Venkataraman H; Beer SB; Bergen LA; Essen Nv; Geerke DP; Vermeulen NP; Commandeur JN
    Chembiochem; 2012 Mar; 13(4):520-3. PubMed ID: 22275147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450BM-3 reduces aldehydes to alcohols through a direct hydride transfer.
    Kaspera R; Sahele T; Lakatos K; Totah RA
    Biochem Biophys Res Commun; 2012 Feb; 418(3):464-8. PubMed ID: 22281497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering cytochrome P450 enzymes for improved activity towards biomimetic 1,4-NADH cofactors.
    Ryan JD; Fish RH; Clark DS
    Chembiochem; 2008 Nov; 9(16):2579-82. PubMed ID: 18816544
    [No Abstract]   [Full Text] [Related]  

  • 20. Improving the activity of cytochrome P450 BM-3 catalyzing indole hydroxylation by directed evolution.
    Pengpai Z; Sheng H; Lehe M; Yinlin L; Zhihua J; Guixiang H
    Appl Biochem Biotechnol; 2013 Sep; 171(1):93-103. PubMed ID: 23817788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.